Empowering Diversity in Clinical Trials.
Empowering Diversity in Clinical Trials.
We make clinical research more accessible to underserved populations to enable faster enrollment, better retention and more representative of real-world populations.
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of geographic barriers. The Science 37 Operating System™ (OS) enables universal access to patients and providers, leading to faster enrollment, greater retention, and a more representative patient population. Leveraging the OS, the Diversity in Clinical Trials business unit’s mission is to collaborate with patients, employees, sponsors, and community organizations who share our vision of eliminating health disparities in underrepresented communities through our patient-centered approach to clinical research.
For additional information, please contact us at diversityinnovation@science37.com.
We make clinical research more accessible to underserved populations to enable faster enrollment, better retention and more representative of real-world populations.
Diverse audiences want to participate in clinical trials but so often, are not asked, overlooked, or unable to access because of geographic barriers. The Science 37 Operating System™ (OS) enables universal access to patients and providers, leading to faster enrollment, greater retention, and a more representative patient population. Leveraging the OS, the Diversity in Clinical Trials business unit’s mission is to collaborate with patients, employees, sponsors, and community organizations who share our vision of eliminating health disparities in underrepresented communities through our patient-centered approach to clinical research.
For additional information, please contact us at diversityinnovation@science37.com.
How to Empower Diversity in Clinical Trials
Science 37’s Global Head, Diversity in Clinical Trials, Ryan Pack, hosts an interactive discussion with leaders from Novartis, PPD, National Urban League and Colorectal Cancer Alliance on how the biopharmaceutical industry can move beyond lip service and truly empower diversity in clinical trials.
How to Empower Diversity in Clinical Trials
Science 37’s Global Head, Diversity in Clinical Trials, Ryan Pack, hosts an interactive discussion with leaders from Novartis, PPD, National Urban League and Colorectal Cancer Alliance on how the biopharmaceutical industry can move beyond lip service and truly empower diversity in clinical trials.
Are you ready for the DEPICT Act?
The Diverse and Equitable Participation in Clinical Trials (DEPICT) Act is a proposed new US legislation aimed at boosting diversity in clinical trials. Once passed, new diversity enrollment targets will be introduced for Investigational New Drug applicants.
To learn more about the DEPICT Act and how our Diversity in Clinical Trials unit can help you reach your diversity targets, speak to one of our experts today.
Are you ready for the DEPICT Act?
The Diverse and Equitable Participation in Clinical Trials (DEPICT) Act is a proposed new US legislation aimed at boosting diversity in clinical trials. Once passed, new diversity enrollment targets will be introduced for Investigational New Drug applicants.
To learn more about the DEPICT Act and how our Diversity in Clinical Trials unit can help you reach your diversity targets, speak to one of our experts today.
